DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Dombret H, Seymour JF, Butrym A et al.
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with > 30% blasts.
Blood 2015;
126: 291-299
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.